Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 87,635 | 97,963 | 82,256 | 78,016 | 68,439 |
Cost of Goods | 25,634 | 28,451 | 24,316 | 24,143 | 22,071 |
Gross Profit | 62,001 | 69,512 | 57,940 | 53,873 | 46,368 |
Operating Expenses | 78,337 | 72,135 | 62,674 | 63,954 | 59,490 |
Operating Income | -15,702 | -2,172 | -4,418 | -9,938 | -13,051 |
Interest Expense | 2,558 | 2,516 | 2,497 | 2,454 | 2,435 |
Other Income | 890 | 769 | 1,059 | 1,163 | 1,240 |
Pre-tax Income | -17,370 | -3,919 | -5,856 | -11,229 | -14,246 |
Income Tax | 343 | 392 | 374 | 381 | 261 |
Net Income Continuous | -17,713 | -4,311 | -6,230 | -11,610 | -14,507 |
Net Income | $-17,713 | $-4,311 | $-6,230 | $-11,610 | $-14,507 |
EPS Basic Total Ops | -0.59 | -0.14 | -0.21 | -0.40 | -0.50 |
EPS Basic Continuous Ops | -0.59 | -0.14 | -0.21 | -0.40 | -0.50 |
EPS Diluted Total Ops | -0.59 | -0.14 | -0.21 | -0.40 | -0.50 |
EPS Diluted Continuous Ops | -0.59 | -0.14 | -0.21 | -0.40 | -0.50 |
EBITDA(a) | $-14,929 | $-1,387 | $-3,827 | $-9,364 | $-12,610 |